Hypertension as a predictive factor of effect of bevacizumab in treatment of colorectal cancer

Yakugaku Zasshi

Volumn 131, Issue 8, 2011, Pages 1251-1257

  Horinouchi, Yuya ^a   Sakurada, Vtakumi ^a   Nakamura, Toshimi ^a   Tajima, Soichiro ^a   Nishisako, Hirotaka ^a   Abe, Shinji ^a   Teraoka, Kazuhiko ^a   Kujime, Toshihide ^a   Kawazoe, Kazuyoshi ^a,b   Minakuchi, Kazuo ^a,b  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Bevacizumab; Colorectal cancer; FOLFIRI; Hypertension; mFOLFOX6; Predictive factor

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; JAPANESE; METASTASIS; NOTE; PREDICTION; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FORECASTING; HUMANS; HYPERTENSION; LEUCOVORIN; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79961038711     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.131.1251     Document Type: Note

References (25)

1. de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., Boni C., Cortes-Funes H., Cervantes A., Freyer G., Papamichael D., Le Bail N., Louvet C., Hen-dler D., de Braud F., Wilson C., Morvan F., Bonetti A., J. Clin. Oncol., 18, 2938-2947 (2000).
2. Goldberg R. M., Sargent D. J., Morton R. F., Fuchs C. S., Ramanathan R. K., Williamson S. K., Findlay B. P., Pitot H. C., Alberts S. R., J. Clin. Oncol., 22, 23-30 (2004).
3. Rothenberg M. L., Oza A. M., Bigelow R. H., Berlin J. D., Marshall J. L., Ramanathan R. K., Hart L. L., Gupta S., Garay C. A., Burger B. G., Le Bail N., Haller D. G., J. Clin. Oncol., 21, 2059-2069 (2003).
4. Douillard J. Y., Cunningham D., Roth A. D., Navarro M., James R. D., Karasek P., Jandik P., Iveson T., Carmichael J., Alakl M., Gruia G., Awad L., Rougier P., Lancet, 355, 1041-1047 (2000).
5. Tournigand C, Andre T., Achille E., Lledo G., Flesh M., Mery-Mignard D., Quinaux E., Couteau C, Buyse M., Ganem G., Landi B., Colin P., Louvet C, de Gramont A., J. Clin. Oncol., 22, 229-237 (2004).
6. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., Berlin J., Baron A., Gring S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross R., Kab-binavar F., N. Engl. J. Med., 350, 2335-2342 (2004).
7. Giantonio B. J., Catalano P. J., Meropol N. J., O'Dwyer P. J., Mitchell E. P., Alberts S. R., Schwartz M. A., Benson A. B 3rd, J. Clin. Oncol., 25, 1539-1544 (2007).
8. Saltz L. B., Clarke S., Dfáaz-Rubio E., Scheithauer W., Figer A., Wong R., Koski S., Lichinitser M., Yang T. S., Rivera F., Couture F., Sirzen F., Cassidy J., J. Clin. Oncol., 26, 2013-2019 (2008).
9. Fuchs C. S., Marshall J., Mitchell E., Wier-zbicki R., Ganju V., Jeffery M., Schulz J., Richards D., Soufi-Mahjoubi R., Wang B., Barrueco J., J. Clin. Oncol., 25, 4779-4786 (2007).
10. Fuchs C. S., Marshall J., Barrueco J., J. Clin. Oncol., 26, 689-690 (2008).
11. Presta L. G., Chen H., O'Connor S. J., Chisholm V., Meng Y. G., Krummen L., Winkler M., Ferrara N., Cancer Res., 57, 4593-4599 (1997).
12. Willett C. G., Boucher Y., di Tomaso E., Duda D. G., Munn L. L., Tong R. T., Chung D. C, Sahani D. V., Kalva S. P., Kozin S. V., Mino M., Cohen K. S., Scadden D. T., Hartford A. C, Fischman A. J., Clark J. W., Ryan D. P., Zhu A. X., Blaszkowsky L. S., Chen H. X., Shellito P. C, Lauwers G. Y., Jain R. K., Nat. Med., 10, 145-147 (2004).
13. JSCCR Guidelines 2010 for the Treatment of Colorectal Cancer, ed. by Japanese Society for Cancer of the Colon and Rectum, KANE-HARA & CO., LTD., Tokyo, 2010, pp. 24-29.
14. Zhu X., Wu S., Dahut W. L., Parikh C. R., Am. J. Kidney Dis., 49, 186-193 (2007).
15. Levy B. I., Ann. Oncol., 20, 200-203 (2009).
16. Mir O., Ropert S., Alexandre J., Goldwasser F., Ann. Oncol., 20, 967-970 (2009).
17. Rini B. I., Schiller J. H., Fruehauf J. P., Cohen E. E., Tarazi J. C, Rosbrook B., Ricart A.D., Olszanski A.J., Kim S., Spano J., J. Clin. Oncol.,26(Suppl.),3543 (2008).
18. Dahlberg S. E., Sandler A. B., Brahmer J. R., Schiller J. H., Johnson D. H., J. Clin. Oncol., 28, 949-954 (2010).
19. Hurwitz H., Douglas P. S., Middleton J. P., Sledge G. W., Johnson D. H., Reardon D. A., Chen D., Rosen O., J. Clin. Oncol., 28 (Suppl.) 3039 (2010).
20. Osterlund P., Soveri L. M., Isoniemi H., Poussa T., Alanko T., Bono P., Br. J. Cancer, 104, 599-604 (2011).
21. Granger J. P., Hypertension, 54, 465-467 (2009).
22. Wacker B., Nagrani T., Weinberg J., Witt K., Clark G., Cagnoni P. J., Clin. Cancer Res., 13, 3913-3921 (2007).
23. Saltz L. B., Meropol N. J., Loehrer P. J. Sr., Needle M. N., Kopit J., Mayer R. J., J. Clin. Oncol., 22, 1201-1208 (2004).
24. Cunningham D., Humblet Y., Siena S., Khayat D., Bleiberg H., Santoro A., Bets D., Mueser M., Harstrick A., Verslype C, Chau I., Van Cutsem E., N. Engl. J. Med., 351, 337-345 (2004).
25. Jubb A. M., Harris A. L., Lancet Oncol., 11, 1172-1183 (2010).